Web Content Management
PRODUCTS
-
Australia is a preferred destination for early phase trials because of simple and fast regulatory stream and lucrative R&D cash refund scheme.
-
Bridge regulatory gaps in visual inspection and improve product quality by managing defects throughout the product lifecycle. Get a better understanding of how a centralized data repository can help.
-
Test of Homepage Bucket HTML In Product Document TypeTest of Homepage Bucket HTML In Product Document Type. Test of Homepage Bucket HTML In Product Document Type. Test of Homepage Bucket HTML In Product Document Type Test of Homepage Bucket HTML In Product Document Type.
Test of Homepage Bucket HTML In Product Document Type Test of Homepage Bucket HTML In Product Document Type.
-
Neither traditional nor hybrid clinical trials can operate on rigid EDC systems.
They require flexible data collection systems that support protocol amendments without downtime and accept mobile data without hassle. As a cloud-native solution, TrialKit bends to accommodate mid-study changes. And as the first full-featured EDC platform available as a native mobile app, TrialKit flexes to meet the demands of traditional, hybrid/decentralized, and completely remote clinical trials.
Give your team the freedom to build, deploy, and manage their studies, their way—weeks faster than with rigid EDCs and for a fraction of the cost of the major players.
-
At the core of our comprehensive eClinical platform, iMednet EDC is uniquely designed to help sponsors and CROs achieve their clinical research goals. Highly flexible, it enables you to build studies quickly, while easily adapting to complex protocols and mid-study changes with ease.
WHITE PAPERS AND CASE STUDIES
-
Global Pharma Enables Remote Sample Collection With eCOA Solution
Unearth how a worldwide pharmaceutical company was able to facilitate the remote collection of stool specimens from patients at their residences as needed for research on infectious diseases.
-
Regulatory Review Of Promotional Materials
Delve into the challenges, objectives, solutions, and achievements of a regulatory review project undertaken by a mid-size pharmaceutical company across the European Union (EU), Asia-Pacific (APAC), Latin America (LATAM), and the Middle East.
-
Repairing A Cracked Coupling In Under Five Minutes And Without A Service Disruption
Read about a utility that was looking for a quick, cost-effective yet resilient solution that would prevent the disruption of water service to the community and environment.
-
Consider India For Your Next HCC International Trial
Assess the feasibility of India as a potential venue for HCC trials as well as its epidemiology, historical perceptions, and untapped potential for international clinical research opportunities.
-
Leeton Shire Improves Efficiency And Service Levels With An Affordable, Intuitive Digital Solution
Although Leeton Shire already had some digital technologies in place, such as SCADA, GIS and AMI, they lacked hydraulic modeling capabilities and expertise — which is why they turned to Qatium’s open and secure water management platform.
-
How GPRS Expanded Into The Inspection Industry With Envirosight
With a 99.8% accuracy rating on over 250,000 projects, GPRS is well-known in the industry for its commitment to providing safe, comprehensive subsurface solutions.
-
Case Study: Connexin Is Taking The UK's 'Smart Cities' To The Next Level
With Skedulo, Connexin is streamlining processes via automation, increasing connectedness between their office & field teams, and elevating their customer experience.
-
Biotechnology Manufacturing Program Management
Find out how a global biotechnology manufacturing company executing several interrelated projects achieved critical project objectives while adhering to schedule and financial commitments.
-
Advancing Cell And Gene Therapy Clinical Development In 2023
Examine considerations on bringing together the CMC and clinical teams early in the development process, promoting transparency and communication with regulators, and increasing patient access and diversity in clinical trials.
-
Blueprint For Early Phase Clinical Pharmacology Studies In Dermatology
Explore the landscape of dermatological drug development through a comprehensive framework for rational early-phase dermatological trials, centered around five foundational pillars.
-
Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 Study
Explore the success story of an early-stage clinical pharmaceutical company that effectively navigated funding constraints when conducting its Phase 1 study without a third-party CRO.
-
Revolutionizing Biofilm Research: High-Resolution, Real-Time Imaging with ZeGage Optical Profiler
A university lab optimized biofilm research with Zygo’s ZeGage Optical Profiler, enabling high-resolution, real-time, non-contact imaging that accelerates data collection, enhances accuracy, and preserves biofilm integrity.
NEWS
-
SoftServe Unveils New Gen AI Solution 'Drug Discovery,' Built With NVIDIA Blueprints At AWS Re:Invent 202412/3/2024
SoftServe, a premier IT consulting and digital services provider, today announced the debut of its newest Generative AI (Gen AI) solution, Drug Discovery, alongside its partner NVIDIA at AWS re:Invent 2024.
-
Solesis, Parent Company of Charter Medical, to Expand Single-use Manufacturing Capabilities into Costa Rica2/2/2024
The site will expand capabilities to enable development in the fast-growing cardiovascular and advanced therapy markets.
-
Yorkshire Water Models Sewer Data Availability10/2/2025
An ongoing project with Yorkshire Water is taking a proactive approach to combined sewer overflow (CSO) management, shifting from reactive responses to preventative measures - crucial for both regulatory compliance and environmental protection.
-
Reusable Nanofiber Membrane Filters Water Sustainably10/23/2025
The antimicrobial triclosan is widely used in personal hygiene products, textiles and plastics, but when it enters the environment via wastewater, it poses a significant threat to aquatic organisms.
-
CARBOGEN AMCIS Shanghai Site Awarded Drug Manufacturing License From Chinese NMPA4/22/2025
CARBOGEN AMCIS, a Switzerland-based pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company is pleased to announce that its Shanghai facility has successfully obtained its first Drug Manufacturing License (DML) from China’s National Medical Products Administration (NMPA).